As of 2024-12-13, the Fair Value of TME Pharma NV (ALTME.PA) is -0.75 EUR. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.08 EUR, the upside of TME Pharma NV is -1,015.32%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -0.86 | -10.41 | -14.45 | -15.13 | -6.74 | -9.52 |
| YoY growth | 91.99% | -1,110.47% | -38.81% | -4.72% | 55.49% | -201.30% |
| Market Cap (mil) | 3.45 |
| P/E | |
| Forward P/E |
| EPS | -0.15 |
| Avg earnings growth rate | -201.30% |
| TTM earnings | -6.32 |